GeneDx Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of GeneDx Holdings using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-18 | $0.60 | $0.10 | 500.0 % |
Q3 | 2024-10-29 | $0.04 | $-0.21 | 119.0 % |
Q2 | 2024-07-30 | $-0.10 | $-0.30 | 66.7 % |
Q1 | 2024-04-29 | $-0.33 | $-0.67 | 50.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-18 | $95.64M | $82.24M | 16.3 % |
Q3 | 2024-10-29 | $76.87M | $64.99M | 18.3 % |
Q2 | 2024-07-30 | $70.51M | $59.24M | 19.0 % |
Q1 | 2024-04-29 | $62.42M | $49.46M | 26.2 % |
GeneDx Holdings (WGS) is scheduled to report earnings on April 28, 2025. The last reported earnings were for reported on February 18, 2025 for Q4.
The Actual EPS was $0.60, which beat the estimate of $0.10.
The Actual Revenue was $95.6M, which beat the estimate of $82.2M.
Browse earnings estimates, EPS, and revenue on all stocks.